Author

Robert B. Levy

University of MiamiORCID 0000-0003-3664-6578Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Robert B. Levy1 paper · City College of New York

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:DNA methylation· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Henry BarrerasiD· 2 shared Ali KhodoriD· 1 shared Brent J. PfeifferiD· 1 shared Dietlinde WolfiD· 1 shared Dmitry IvanoviD· 1 shared Duneia McManusiD· 1 shared Galina DvoriantchikovaiD· 1 shared Geoffrey R. HilliD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Henry BarrerasORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintMay 2, 2026

The TET-dependent DNA demethylation pathway is the driving force of hematopoiesis

Galina Dvoriantchikova, Michelle Fleishaker, Henry Barreras…·Dmitry Ivanov

This study shows that TET-mediated DNA demethylation is essential for hematopoiesis by activating lineage-specific genes in HSPCs, with loss of TET activity causing hematological malignancies.

DOI 10.64898/2026.04.29.721744

mouseDNA methylation

𝕏 PostBluesky

ImmunologyBloodPeer-reviewedAug 1, 2025

Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues ameliorating GVHD post-HSCT

Duneia McManus, Sabrina N. Copsel, Brent J. Pfeiffer…·Robert B. Levy

This paper shows that pretransplant targeting of TNFRSF25 and CD25 with a TL1A-Ig fusion protein and low-dose IL-2 expands recipient Tregs, reducing GVHD after HSCT while preserving GVL.

4 citations

mouseexperimental assay

𝕏 PostBluesky